Fox Chase Cancer Center Teams Up with Former NFL Player Chris Draft to Host FREE Community Lung Cancer Event
PHILADELPHIA (November 13, 2013)—Fox Chase Cancer Center is teaming up with Chris Draft, former NFL player and Founder, President and CEO of the Chris Draft Family Foundation, to host “Together Facing Lung Cancer”—a FREE educational event for the community. The event will take place on Saturday, November 16 from 1:30 to 4:00 p.m. in the main corridor of the Robert C. Young Pavilion on the Fox Chase Cancer Center campus in northeast Philadelphia (333 Cottman Avenue).
The educational event will give attendees a chance to mingle with oncology experts while learning more about lung cancer, helping raise awareness of the disease, honoring survivors and remembering loved ones. Attendees will also hear from guest speaker, Chris Draft, who founded a non-profit organization in memory of his wife Keasha that is dedicated to empowering families to live healthy lifestyles.
Light refreshments will be served and those attending will receive a free gift. Free parking is available in the East Garage, which connects to the Young Pavilion.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).